[HTML][HTML] Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms

J Kim, H Yoon, J Basak, J Kim - Molecules and cells, 2014 - Elsevier
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

J Kim, H Yoon, J Basak, J Kim - Molecules and cells, 2014 - kiss.kstudy.com
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

JK Kim, HJ Yoon, J Basak, JS Kim - Molecules and Cells, 2014 - oldkmbase.medric.or.kr
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

J Kim, H Yoon, J Basak, J Kim - Molecules and Cells, 2014 - dbpia.co.kr
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

[PDF][PDF] Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

J Kim, H Yoon, J Basak, J Kim - Mol. Cells, 2014 - researchgate.net
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms

J Kim, H Yoon, J Basak, J Kim - Molecules and cells, 2014 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

[PDF][PDF] Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

J Kim, H Yoon, J Basak, J Kim - Mol. Cells, 2014 - Citeseer
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.

J Kim, H Yoon, J Basak - Molecules and Cells, 2014 - europepmc.org
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

[PDF][PDF] Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

J Kim, H Yoon, J Basak, J Kim - Mol. Cells, 2014 - e-sciencecentral.org
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …

[HTML][HTML] Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms

J Kim, H Yoon, J Basak, J Kim - Molecules and Cells, 2014 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is clinically characterized with progressive memory loss and
cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to …